===============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Agreement of 1934
Date of Report (Date of earliest event reported): March 21, 1997
CVS CORPORATION
-----------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
<TABLE>
<S> <C> <C>
Delaware 1-1011 05-0494040
- ---------------------------------------------- ------------------------- ----------------------------------
(State or Other Jurisdiction of (Commission File Number) (IRS Employer Identification No.)
Incorporation)
</TABLE>
One CVS Drive
Woonsocket, Rhode Island 02895
- ----------------------------------------------- -------------------
(Address of Principal Executive Offices) (Zip Code)
(401) 765-1500
---------------------------------------------------
(Registrant's telephone number, including area code)
------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
===============================================================================
ITEM 5.Other Events.
On March 21, 1997, CVS Corporation, a Delaware corporation
("CVS"), and Revco D.S., Inc., a Delaware corporation ("Revco"), received a
request from the Federal Trade Commission for additional information relating
to CVS' proposed acquisition of Revco.
A press release announcing such request was issued on March 21,
1997. The information contained in the press release is incorporated herein
by reference. The press release is attached hereto as Exhibit 99.1.
ITEM 7(c). Exhibits.
Exhibit 99.1 Press Release dated March 21, 1997.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
CVS CORPORATION
Dated: March 21, 1997 By: /s/ Charles Conaway
-----------------------------
Name:Charles Conaway
Title:Chief Financial Officer
INDEX TO EXHIBITS
Sequential
Exhibit No. Description Page No.
- ----------- ----------- ----------
Exhibit 99.1 Press Release dated March 21, 1997.
EXHIBIT 99.1
Contacts: Nancy Christal/Fred McGrail
CVS Corporation
(914) 722-4704
(401) 765-1500 Ext. 4630
Jim Fingeroth/Wendi Kopsick
Kekst and Company
(212) 593-2655
FOR IMMEDIATE RELEASE
---------------------
WOONSOCKET, RI, March 21, 1997 -- CVS Corp. (NYSE: CVS) today
announced that it and Revco D.S., Inc. (NYSE: RXR) have received a request for
additional information from the Federal Trade Commission relating to CVS'
proposed acquisition of Revco. The parties intend to respond promptly and do
not expect the request to delay completion of the transaction by mid-year
1997. On February 7, 1997, CVS announced it had signed a definitive agreement
providing for the combination of CVS and Revco in a stock transaction valued at
approximately $2.8 billion, plus the assumption of approximately $900 million
of Revco debt. Revco, with 1996 annual sales of approximately $5.1 billion,
operates nearly 2,600 stores in 17 midwestern, southeastern and eastern
states. CVS, with annual sales of $5.5 billion in 1996, is a leading drug
store chain in the northeast and middle atlantic regions. As of February 22,
1997, CVS operated 1,417 stores in 14 states and the District of Columbia.
